Institute of Enzymology, Research Centre for Natural Sciences of the Hungarian Academy of Sciences, Budapest, H-1117, Hungary.
Institute of Biochemistry, Biological Research Centre of the Hungarian Academy of Sciences, Szeged, H-6726, Hungary.
Nat Commun. 2020 Mar 6;11(1):1223. doi: 10.1038/s41467-020-15021-5.
Increased fidelity mutants of the SpCas9 nuclease constitute the most promising approach to mitigating its off-target effects. However, these variants are effective only in a restricted target space, and many of them are reported to work less efficiently when applied in clinically relevant, pre-assembled, ribonucleoprotein forms. The low tolerance to 5'-extended, 21G-sgRNAs contributes, to a great extent, to their decreased performance. Here, we report the generation of Blackjack SpCas9 variant that shows increased fidelity yet remain effective with 21G-sgRNAs. Introducing Blackjack mutations into previously reported increased fidelity variants make them effective with 21G-sgRNAs and increases their fidelity. Two "Blackjack" nucleases, eSpCas9-plus and SpCas9-HF1-plus are superior variants of eSpCas9 and SpCas9-HF1, respectively, possessing matching on-target activity and fidelity but retaining activity with 21G-sgRNAs. They facilitate the use of existing pooled sgRNA libraries with higher specificity and show similar activities whether delivered as plasmids or as pre-assembled ribonucleoproteins.
提高 SpCas9 核酸酶的保真度突变体构成了减轻其脱靶效应的最有前途的方法。然而,这些变体仅在有限的靶标空间内有效,并且据报道,当以临床相关的预组装核糖核蛋白形式应用时,其中许多变体的效率较低。对 5'-延伸的 21G-sgRNA 的低容忍度在很大程度上导致了它们性能的降低。在这里,我们报告了 Blackjack SpCas9 变体的产生,该变体显示出更高的保真度,但仍能与 21G-sgRNA 有效作用。将 Blackjack 突变引入先前报道的提高保真度的变体中,使它们能够与 21G-sgRNA 有效作用,并提高其保真度。两个“Blackjack”核酸酶,eSpCas9-plus 和 SpCas9-HF1-plus,分别是 eSpCas9 和 SpCas9-HF1 的优越变体,具有匹配的靶标活性和保真度,但保留了与 21G-sgRNA 的活性。它们促进了使用具有更高特异性的现有池 sgRNA 文库,并且无论作为质粒还是作为预组装核糖核蛋白递送,其活性相似。